CRISPR/Cas9-mediated genome editing can inhibit virus infection by targeting the conserved regions of the viral genomic DNA. Unexpectedly, we found previously that pseudorabies virus (PRV) could escape from CRISPR/Cas9-mediated inhibition.
| INTRODUCTION
CRISPR Cas9-mediated genome editing can inhibit virus infection by targeting the conserved regions of the viral genomic DNA.
1-6
Previously, we constructed a cell line stably expressing Cas9 endonuclease and sgRNA targeting the conserved UL30 gene of pseudorabies virus (PRV), and found that the sgRNA could specifically target and cleave the conserved UL30 gene, resulting in the robust suppression of PRV infection. 7 Unexpectedly, PRV could escape from CRISPRCas9-mediated inhibition. 7 There have been reports that Cas9-mediated cleavage can be disrupted by cell factors, such as interactions between genomic context and internal gRNA, 8 type I interferons, 9 and anti-CRISPR proteins. 10 In order to elucidate whether the escape of PRV from Cas9-mediated inhibition was due to cell deficiencies, such as genetic instability of sgRNA or Cas9 protein, the positive cells were passaged 10 times and PRV infection in the sgRNA-expressing cells was evaluated in the present study.
| ME TH ODS
Previously, we found that there was no significant difference among PK-15, PX459, and PX459-PRV cells, and the expression of sgRNA had no notable effect or toxicity on cell viability. 7 In the present study, sgRNA-expressing cells (PX459-PRV) and control cells (PX459 and PK-15) were seeded onto 12-well plates. At 70%-80% confluency, the cells were infected with 500 lL of PRV (6 TCID . 12 Therefore, studies to elucidate the mechanism of PRV escape are urgently needed. We report here that subculturing cells has no effect on Cas9-mediated cleavage of PRV and we are currently investigating the mechanism of the NHEJ pathway involved in PRV escape. The occurrence of viral escape from CRISPR Cas9-mediated inhibition may limit the use of Cas9/sgRNA in virus control or therapy. 7 Combinations of two strong sgRNAs targeting different regions of the viral genome, or RNAi and CRISPR Cas9 can completely abrogate viral replication and prevent viral escape. 13, 14 Therefore, research into the combination of 2 strong sgRNAs targeting different regions of the PRV genome is ongoing.
In conclusion, subculturing cells has no effect on Cas9-mediated cleavage of PRV. PX459-PRV cells from different passages can stably express sgRNA to facilitate Cas9/sgRNA cleavage on the UL30 gene of PRV.
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